Amerikanische Gesellschaft für Hirudotherapie

Success rates of finger revascularization and replantation

Retrospective study published in Plast Reconstr Surg Glob Open (2024)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportKlinische StudienKobayashi et al. · Plastic and reconstructive surgery. Global open, 2024

Abstract

BACKGROUND: Revascularization surgery has been reported to have a higher success rate than replantation due to sufficient venous return. However, in complex cases, success depends on a wide range of indications. This study aimed to investigate success rates in cohorts that included severe cases. METHODS: This single-center, noninterventional, retrospective cohort study included 292 patients (349 digits) who underwent revascularization or replantation at our institution between January 2000 and December 2022. Sex, age, smoking history, comorbidities, affected digit, amputation level, complete or incomplete amputation, type of fracture and mechanism, artery diameter, needle, vein anastomosis in the revascularization subgroup, vein grafting, warm ischemic time, and outcomes were investigated and compared between the revascularization and replantation subgroups of the distal and proximal amputation groups. RESULTS: In the distal amputation group, the arterial diameter in the revascularization subgroup was larger than that in the replantation subgroup (P < 0.05). In the proximal amputation group, the revascularization subgroup had a lower frequency of multiple amputations than the replantation subgroup (P < 0.05). Vein grafts were more frequently used in both revascularization subgroups than in the replantation subgroups (P < 0.05). However, the other injury severity indices were similar, and the success rates were not significantly different between the subgroups. CONCLUSIONS: The revascularization success rate was similar to that of replantation. Vein anastomosis or vein grafting to the veins should be advocated for revascularization in severe cases where skin bridges may not have sufficient venous return.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Zusammenfassung

Retrospective analysis of finger revascularization and replantation success rates.

Warum dies für die Hirudotherapie relevant ist

This retrospective cohort study evaluated the success rates and injury severity indices of 292 patients (349 digits) undergoing finger revascularization or replantation over a 22-year period. The abstract emphasizes that venous return via vein anastomosis or grafting is crucial for successful revascularization in severe cases. Venous congestion is a primary indication for hirudotherapy in reconstructive surgery, suggesting a clinical intersection where leeches are typically used to salvage compromised digits. However, the abstract strictly focuses on surgical outcomes and makes absolutely no mention of leeches, medicinal leech therapy, or the leech secretome. Therefore, its relevance to ASH is entirely unstated and only theoretical.

Zitation

Success rates of finger revascularization and replantation.

Kobayashi et al. · Plastic and reconstructive surgery. Global open, 2024

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.